View More Recent Stories
-
Agilent Technologies (A) Completes Acquisition of BIOVECTRA
-
Agilent Technologies (A) Declares $0.236 Quarterly Dividend; 0.7% Yield
-
Agilent Technologies (A) Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
-
Agilent Technologies (A) Files for Debt Offering
-
KeyBanc Reiterates Sector Weight Rating on Agilent (A)
-
Agilent (A) PT Raised to $160 at TD Cowen
-
Agilent (A) PT Raised to $147 at BofA Securities
-
Agilent (A) PT Raised to $135 at Evercore ISI
-
Agilent (A) PT Raised to $165 at Citi
-
Agilent Technologies (A) Tops Q3 EPS by 6c; revises guidance
-
Agilent Technologies (A) call put ratio 2.7 calls to 1 put into quarter results
-
Agilent Technologies (A) September straddle priced into quarter results
-
Agilent Technologies (A) Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
-
Agilent Technologies (A) Acquires Sigsense
-
Jefferies Reiterates Hold Rating on Agilent (A)
-
Agilent Technologies (A) to Acquire BIOVECTRA
-
10 policies if Trump wins and stock implications: Jefferies
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview
-
Agilent Technologies (A) Appoints Bret DiMarco as Chief Legal Officer
-
Wolfe Research Downgrades Agilent (A) to Peerperform
-
Citi Reiterates Neutral Rating on Agilent (A)
-
Increasing unusual put option volume: MNST PLAY BMBL MAXN SPCE HPE XLI MGA A URA

